Cover
Vol. 13 No. 1 (2023)

Published: May 31, 2023

Pages: 95-110

Research Article

Insulin-Like Factor 3 (INSL3) in Serum and Follicular Fluid: Realtion With Marker Of Ovarian Reserve.

Maroua K. Lateef 1 Muayad S. Abbod Mufeda A. Jwad
1High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al Nahrain University, Baghdad, Iraq.
History
  • Received: April 7, 2023
  • Accepted: April 30, 2023
  • Available Online: May 8, 2023
DOI

https://doi.org/10.28969/IJEIR.v13.i1.r8.23

Abstract

Granulosa cells produce most ovarian function indicators in infertile women like estradiol, AMH, and inhibin B. Female peptide hormone insulin-like factor 3 is produced by theca cell. Signaling of insulin-like factor 3 from theca cell stimulates antral follicle development and theca androgen production. To investigate how INSL3 levels may be a theca cell marker of ovarian reserve and the association with current markers of ovarian reserve, including AFC, FSH, E2, and AMH, in infertile women undertaking assisted reproduction. In this cross-sectional study, 75 Iraqi infertile couples were chosen at Al-Nahrain University's High Institute for Infertility Diagnosis and Assisted Reproductive Technologies from October 2022 to April 2023 for the ICSI cycle. Based on the levels of INSL3 in the serum on the day 2 of the menstrual cycle and on the day of retrieving oocyte in the follicular fluid. A comparison was made with current ovarian reserve markers (AFC, FSH, E2, and AMH) .From 75 infertile women undergoing intracytoplasmic sperm injection (ICSI), 21 of them achieved pregnancy. Positive Significant relations were found between serum INSL3 levels and anti-mullerian hormone (AMH and antral follicle count. there were no significant relationships between follicular fluids INSL3 with serum LH, FSH and E2 . The study provides compelling evidence for the significant role of INSL3 in female fertility and its association with the success of intracytoplasmic sperm injection (ICSI). Positive correlations between serum INSL3 levels and anti-mullerian hormone (AMH) and Antral follicle count AFC indicate its potential involvement in ovarian reserve and hormonal regulation.

Keywords

References

  1. World Health Organization 2020, World Health Organization. Available online at: https://www.who.int/reproductivehealth/topic s/en
  2. El-Hussein OG, Ahmed MA, Suliman SO, Yahya LI & Adam I 2019, “Epidemiology of infertility and characteristics of infertile couples requesting assisted reproduction in a low-resource setting in Africa, Sudan,” Fertility. Research and Practice, vol.5, no.7. https://doi.org/10.1186/s40738-019-0060-1 .
  3. Yatsenko SA, Rajkovic A 2019, “Genetics of human female infertility,” Biology of Reproduction vol.101, pp.549–566. https://doi.org/10.1093/biolre/ioz084.
  4. Koshy S & Anuradha K 2022, “A Review on AI methods for the Prediction of Infertility in Women, “International Journal of Engineering Technology and Management Sciences, vol. 6, pp.287. DOI:10.46647/ijetms. 2022.v06i05.042 .
  5. Esteban-Lopez M & Agoulnik A 2020,” Diverse functions of insulin-like three peptides,” The Journal of Endocrinology ، vol. 24, pp.1– 12. https://doi.org/10.1530/JOE-20- 0168.
  6. Hagen C, Mieritz MG, Nielsen JE, Anand- Ivell R, Ivell R & Juul A 2015, “Longitudinal assessment of circulating INSL3 levels in healthy peripubertal girls”, Fertility and Sterility, vol.103, pp.780–786. https://dx.doi.org/10.1016/j.fertnstert.2014.1 1.014.
  7. Ivell R & Anand-Ivell R 2018,” Insulin- like peptide 3 (INSL3) is a major regulator of female reproductive physiology”, Human Reproduction Update, vol.24, pp. 639–651. doi:10.1093/humupd/dmy029.
  8. Anand-Ivell R, Tremellen K, Dai Y, Heng K, Yoshida M, Knight PG & Hale GE, Ivell R 2013, “Circulating insulin-like factor 3 (INSL3) in healthy and infertile women”, Human Reproduction, vol.28, pp.3093–3102. doi:10.1093/humrep/det349.
  9. Satchell L, Glister C, Bleach E, Bicknell A, Dai Y, Anand-Ivell R, Ivell R & Knight PG 2013, “Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles”, Endocrinology, Vol.154, pp.1897– 1906. https://doi.org/10.1210/en.2012-2232.
  10. Xue K, Kim JY, Liu JY & Tsang BK 2014, “Insulin-like 3-induced rat preantral follicular growth is mediated by growth differentiation factor 9”, Endocrinology, vol.155, pp.156-167. https://doi.org/10.1210/en.2013-1491.
  11. Zhu C, Luo W, Li Z, Zhang X, Hu J, Zhao S, Jiao X & Qin Y 2021,” New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency”, Fertility& Sterility, vol. 115, pp. 455– 62. https://doi.org/10.1016/j.fertnstert.2020.08.0 05.
  12. Wang, C.-W, Kuo, C.-Y, Chen, C.-H, Hsieh, Y.-H & Su E.C.-Y 2022,” Predicting clinical pregnancy using clinical features and machine learning algorithms in in vitro fertilization,” PLoS ONE, vol. 17, pp.e0267554. https://doi.org/10.1371/journal.pone.0267554
  13. Gambineri A, Patton L, Prontera O, Fanelli F, Ciampaglia W, Cognigni GE, Pagotto U & Pasquali R 2011, “Basal insulin- like factor 3 levels predict functional ovarian hyper an drogenism in the polycystic ovary syndrome”, Journal of Endocrinology ، vol.34, pp685–691. doi: 10.1210/jc.2006-1678.
  14. Marinelli S, Napoletano G, Straccamore M, Basile G 2022, “Female obesity and infertility: outcomes and regulatory guidance,” Acta Biomedica, vol. 93, pp. e2022278.
  15. Gautam D, Purandure N, Maxwell C, Rosser ML, O'Brien P, Mocanu E, | McKeown C, Jaideep Malhotra J & McAuliffe FM 2023,” The challenges of obesity for fertility: a FIGO literature review,” International Journal of Gynecology & Obstetrics, 2023, vol.160, pp. 50- 55. https://doi.org/10.1002/ijgo.14538.
  16. Bakhtiari M, Babaei T, Safarpour M, Esmaeili M, Esmaeili M & Asgari R 2022, “Investigating the Factors Affecting the ICSI (microinjection) Success in Infertile People Referred to an Infertility Treatment Center in Western Iran from 2011 to 2017”. Journal of Obstetrics, Gynecology and Cancer Research, vol. 5, pp.115-25. https://doi.org/10.30699/jogcr.5.3.115.
  17. Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A & Pasquali R 2013, “Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern”, Journal of Clinical Endocrinol & Metabolism vol.98, pp.1575–1582. doi: 10.1210/jc.2013-1107.
  18. Seyam E & Hefzy E 2018,” Evaluation of the correlation between insulin-like factor 3, polycystic ovary syndrome, and ovarian maldescent”, Gynecology and Endocrinology, vol.34, pp. 481-488. doi: 10.1080/09513590.2017.1416462.
  19. Hanna CB, Yao S, Patta MC, Jensen JT, Wu X 2010,” Expression of insulin-like 3 (INSL3 and differential splicing of its receptor in the ovary of rhesus macaques” ، Reproductive Biology and Endocrinology, vol.8, pp.150. DOI: 10.1095/biolreprod.109.081984.
  20. Dai Y, Ivell R, Liu X, Janowski D & Anand-Ivell R 2017,” Relaxin-family peptide receptors 1 and 2 are fully functional in the bovine”, Fronteir Physiology, vol.8, pp.359. doi: 10.3389/fphys.2017.00359.